title: Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia.
abstract: Immune thrombocytopenia (ITP) is an acquired bleeding autoimmune disorder characterized by a markedly decreased blood platelet count. The disorder is variable, frequently having an acute onset of limited duration in children and a more chronic course in adults. A number of therapeutic agents have demonstrated efficacy in increasing the platelet counts in both children and adults. Anti-RhD immunoglobulin (anti-D) is one such agent, and has been successfully used in the setting of both acute and chronic immune thrombocytopenia. In this report we review the use of anti-D in the management of ITP. While the FDA-approved dose of 50 mg/kg has documented efficacy in increasing platelet counts in approximately 80% of children and 70% of adults, a higher dose of 75 microg/kg has been shown to result in a more rapid increase in platelet count without a greater reduction in hemoglobin. Anti-D is generally ineffective in patients who have failed splenectomy. Anti-RhD therapy has been shown capable of delaying splenectomy in adult patients, but does not significantly increase the total number of patients in whom the procedure can be avoided. Anti-D therapy appears to inhibit macrophage phagocytosis by a combination of both FcR blockade and inflammatory cytokine inhibition of platelet phagocytosis within the spleen. Anti-RhD treatment is associated with mild to moderate infusion toxicities. Rare life-threatening toxicities such as hemoglobinuria, acute renal failure and disseminated intravascular coagulation have been reported. Recommendations have been proposed to reduce the risk of these complications. Anti-D immunoglobulin can be an effective option for rapidly increasing platelet counts in patients with symptomatic ITP.
authors.affiliation: Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California-Keck School of Medicine, Los Angeles, CA, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Cheung
authors.forename: Howard A
authors.initials: HA
authors.lastname: Liebman
references.citation: Blood. 1991 May 1;77(9):1884-93
references.pmid: 1850307
references.citation: Blood. 2002 Mar 15;99(6):1922-7
references.pmid: 11877261
references.citation: Haematologica. 1987 Nov-Dec;72(6):529-32
references.pmid: 3126110
references.citation: Blut. 1986 Feb;52(2):117-21
references.pmid: 3081067
references.citation: Zentralbl Gynakol. 1997;119(5):204-10
references.pmid: 9281253
references.citation: Blood. 2004 Feb 15;103(4):1364-9
references.pmid: 14576051
references.citation: Blood. 1988 May;71(5):1499-502
references.pmid: 2833961
references.citation: Br J Haematol. 1994 Nov;88(3):618-20
references.pmid: 7819076
references.citation: Am J Hematol. 2003 Nov;74(3):161-9
references.pmid: 14587042
references.citation: Blut. 1984 Jul;49(1):29-35
references.pmid: 6430368
references.citation: Am J Hematol. 1986 Jul;22(3):241-50
references.pmid: 3087158
references.citation: Curr Opin Hematol. 2007 Sep;14(5):526-34
references.pmid: 17934363
references.citation: Blood. 2005 Sep 1;106(5):1532-7
references.pmid: 15878975
references.citation: Clin Lab Haematol. 1988;10(3):275-84
references.pmid: 2846228
references.citation: Lancet. 1994 Sep 10;344(8924):703-7
references.pmid: 7915773
references.citation: Semin Hematol. 1998 Jan;35(1 Suppl 1):9-13
references.pmid: 9523744
references.citation: Blood. 2007 Jun 15;109(12):5527; author reply 5528
references.pmid: 17554071
references.citation: Nat Med. 2006 Jun;12(6):688-92
references.pmid: 16715090
references.citation: Blood. 1997 Apr 15;89(8):2689-700
references.pmid: 9108386
references.citation: Br J Haematol. 2004 Feb;124(4):511-8
references.pmid: 14984503
references.citation: Blood. 2003 Oct 15;102(8):2862-7
references.pmid: 12829590
references.citation: Br J Haematol. 1992 Mar;80(3):337-40
references.pmid: 1581213
references.citation: Can Med Assoc J. 1980 Dec 6;123(11):1121-7
references.pmid: 6161687
references.citation: J Pediatr. 1992 Apr;120(4 Pt 1):522-7
references.pmid: 1313096
references.citation: Eur J Pediatr. 1986 Aug;145(3):166-9
references.pmid: 3021462
references.citation: Semin Hematol. 2007 Oct;44(4 Suppl 5):S24-34
references.pmid: 18096469
references.citation: Lancet. 2008 Feb 2;371(9610):395-403
references.pmid: 18242413
references.citation: Br J Haematol. 2001 Mar;112(4):1076-8
references.pmid: 11298610
references.citation: Curr Opin Hematol. 2007 Sep;14(5):511-4
references.pmid: 17934360
references.citation: Transfus Med Rev. 2008 Apr;22(2):103-16
references.pmid: 18353251
references.citation: Vox Sang. 2007 Aug;93(2):99-111
references.pmid: 17683353
references.citation: Blood. 2000 Apr 15;95(8):2523-9
references.pmid: 10753830
references.citation: Br J Haematol. 2008 Apr;141(1):109-19
references.pmid: 18279459
references.citation: N Engl J Med. 2002 Mar 28;346(13):995-1008
references.pmid: 11919310
references.citation: Curr Opin Hematol. 2007 Sep;14(5):535-56
references.pmid: 17934364
references.citation: Haematologica. 1992 May-Jun;77(3):248-52
references.pmid: 1330848